The present disclosure provides a method for reducing the risk of autoimmune disease by administering a composition comprising peptides selected from a casein hydrolysate. Such a composition, may reduce the symptoms of autoimmune disease and may be a treatment for autoimmune disease, especially type 1 diabetes. Preferably, the hydrolysate consists of peptides with a molecular weight of more than 500 Da.
申请公布号
SG11201505692Q(A)
申请公布日期
2015.08.28
申请号
SG11201505692Q
申请日期
2014.03.11
申请人
MJN U.S. HOLDINGS LLC
发明人
HONDMANN, DIRK,;VAN TOL, ERIC A.F.,;GROSS, GABRIELE,;SCHOEMAKER, MARIEKE H.,;LAMBERS, TEARTSE TIM,